Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jae‐Hyeok Kang"'
Autor:
Jae-Hyeok Kang, Nizam Uddin, Seungmo Kim, Yi Zhao, Ki-Chun Yoo, Min-Jung Kim, Sung-Ah Hong, Sangsu Bae, Jeong-Yeon Lee, Incheol Shin, Young Woo Jin, Heather M. O’Hagan, Joo Mi Yi, Su-Jae Lee
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Triple-negative breast cancer (TNBC), the most aggressive subtype, presents a critical challenge due to the absence of approved targeted therapies. Hence, there is an urgent need to identify effective therapeutic targets for this condition.
Externí odkaz:
https://doaj.org/article/6c5a1e8d71c14b51abf556d24cb132c7
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Breast cancer is the most common type of cancer in women, and approximately 70% of all breast cancer patients use endocrine therapy, such as estrogen receptor modulators and aromatase inhibitors. In particular, triple-negative breast cancer
Externí odkaz:
https://doaj.org/article/22e58af17a024997a2c91dc1f539f362
Publikováno v:
Cell Death and Disease, Vol 13, Iss 4, Pp 1-11 (2022)
Abstract Colorectal cancer (CRC) has a 5-year survival rate of
Externí odkaz:
https://doaj.org/article/053eaa3add874b60aa6726247dd094c6
Autor:
Yan-Hong Cui, Jae-Hyeok Kang, Yongjoon Suh, Yi Zhao, Joo Mi Yi, In-Hwa Bae, Hae-June Lee, Dong Won Park, Min-Jung Kim, Su-Jae Lee
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/fa139bdd9c6147959edb280c129e6b00
Autor:
Yi Zhao, Nayeon Shim, Yan-Hong Cui, Jae-Hyeok Kang, Ki-Chun Yoo, Seungmo Kim, Joo Mi Yi, Min-Jung Kim, Jai Hoon Yoon, Su-Jae Lee
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/b099222e375145fc8ff3a03c7b488e76
Autor:
Seung‐Mo Kim, Eun‐Jung Lim, Ki‐Chun Yoo, Yi Zhao, Jae‐Hyeok Kang, Eun‐Ji Lim, Incheol Shin, Seok‐Gu Kang, Han Woong Lim, Su‐Jae Lee
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 8, Pp n/a-n/a (2022)
Abstract Background The biological function of mesenchymal stem‐like cells (MSLCs), a type of stromal cells, in the regulation of the tumour microenvironment is unclear. Here, we investigated the molecular mechanisms underlying extracellular matrix
Externí odkaz:
https://doaj.org/article/a8088d93f69a4b26a9da35e9df8fdb23
Autor:
Ki‐Chun Yoo, Jae‐Hyeok Kang, Mi‐Young Choi, Yongjoon Suh, Yi Zhao, Min‐Jung Kim, Jong Hee Chang, Jin‐Kyoung Shim, Seon‐Jin Yoon, Seok‐Gu Kang, Su‐Jae Lee
Publikováno v:
Advanced Science, Vol 9, Iss 2, Pp n/a-n/a (2022)
Abstract Despite aggressive clinical treatment, recurrence of glioblastoma multiforme (GBM) is unavoidable, and the clinical outcome is still poor. A convincing explanation is the phenotypic transition of GBM cells upon aggressive treatment such as r
Externí odkaz:
https://doaj.org/article/eb08756678be4f74a0d7d5071c9c65e2
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/84cbaf63d5ec4430b5c5a3bbe8a8b5ee
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/b4251f96648d48fab5a2aa1ad063466f
Autor:
Neha Kaushik, Min-Jung Kim, Nagendra Kumar Kaushik, Jae Kyung Myung, Mi-Young Choi, Jae-Hyeok Kang, Hyuk-Jin Cha, Cha-Soon Kim, Seon-Young Nam, Su-Jae Lee
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background The existence of differentiated thyroid cells is critical to respond radioactive iodide treatment strategy in thyroid cancer, and loss of the differentiated phenotype is a trademark of iodide-refractive thyroid disease. While high
Externí odkaz:
https://doaj.org/article/beb9edeb44464d99831ab4b1fa13a106